oncology
FDA grants fast track designation to myelofibrosis, nasopharyngeal cancer therapies
Posted in Medicine on 21st Jul, 2023
by Alex Muller
The FDA granted fast track designation to two oncology therapies.
Liquid biopsy may aid in diagnosis, surveillance of HPV-associated oropharyngeal cancer
Posted in Medicine on 20th Jul, 2023
by Alex Muller
Tumor tissue-modified viral-HPV DNA demonstrated 91.5% sensitivity among patients in the diagnostic cohort and 88.4% in the surveillance cohort.
Tislelizumab Plus Bevacizumab/Chemo Demonstrates Early Efficacy in Cervical Cancer
Posted in Medicine on 20th Jul, 2023
by Alex Muller
The addition of the PD-L1 inhibitor tislelizumab to standard bevacizumab and platinum-doublet chemotherapy in the first-line setting prolonged progression-free survival, produced encouraging responses, and was well tolerated in patients with cervical cancer.
Two Drugs May Be Better Than One for Resistant Breast Cancers
Posted in Medicine on 18th Jun, 2023
by Alex Muller
Overall, the study suggests that combining new CDK2 inhibitors with CDK4/6 inhibitors – such as palbociclib, ribociclib and abemaciclib – could be effective for patients with either intrinsic or acquired resistance.
Removing senescent immune cells could be the key to preventing some lung cancers
Posted in Medicine on 18th Jun, 2023
by Alex Muller
So, while this research is still in early stages, it could provide hope for an effective way to not only treat, but to intercept and prevent lung cancer, one of the biggest cancers of unmet need.